title: Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease.
authors.affiliation: From the French National Reference Centre for Wilson's Disease (J.-M.T., F.W.), Biological Toxicology Laboratory (S.E.B., J.P.), Neuroradiology (J.-P.G.), and Laboratoire de Biochimie et Biologie Moléculaire (P.C.), AP-HP, Hôpital Lariboisière, Paris; and National Reference Centre for Inborn Errors of Metabolism (F.F.), INSERM U954, Nancy, France.
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Trocello
authors.forename: France
authors.initials: F
authors.lastname: Woimant
authors.forename: Souleiman
authors.initials: S
authors.lastname: El Balkhi
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Guichard
authors.forename: Joel
authors.initials: J
authors.lastname: Poupon
authors.forename: Philippe
authors.initials: P
authors.lastname: Chappuis
authors.forename: Francois
authors.initials: F
authors.lastname: Feillet
mesh_terms: D000293:Adolescent; D002540:Cerebral Cortex / Q000473:pathology*; D054022:Cerebrum / Q000473:pathology*; D002614:Chelating Agents / Q000627:therapeutic use; D015913:Chelation Therapy / Q000379:methods; D003342:Corpus Striatum / Q000473:pathology*; D006527:Hepatolenticular Degeneration / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D056784:Leukoencephalopathies / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D012640:Seizures / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D002614:Chelating Agents; D010396:Penicillamine